A Study of LY3039478 in Participants With Advanced or Metastatic Solid Tumors

Clinical trial NCT02784795 · TERMINATED

Trial details

NCT number: NCT02784795
Sponsor: Eli Lilly and Company
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor Breast Cancer Colon Cancer Cholangiocarcinoma Soft Tissue Sarcoma

Start date: 2016-11-04
Primary completion: 2018-08-09
Enrollment: 94

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.